Skip to content
New York Public Prosecutor, Lettia James, has warned New York Hospitals that compliance with the executive of the White House seeking to end the gender medical care for sexually transformed youth can violate the state law.
The warning, in a speech, puts the Office of the Prosecutor on Monday morning to health care providers and other organizations, hospitals at the center of the conflict between the federal government and state authorities.
Last week, the White House issued an executive order threatening to block federal financing from hospitals that provide confirmed gender treatments-including puberty blockers and hormonal treatments-to sexually transformed youth under the age of 19. York City Hospital has started canceling appointments for some children, according to two families spoke to the New York Times.
But the public prosecutor’s speech warns hospitals that they may risk violating the laws of combating discrimination in New York by refusing to care for sexually transformed patients in children.
“Regardless of the availability of federal financing, we write to remind you of increasing your obligations to comply with the laws of New York State,” the letter said. The matter continued, “the choice of rejecting services for a group of individuals based on their protected condition, such as blocking the availability of services from sexually transformed individuals based on their sexual identity or the diagnosis of dysfunction, while providing such services to individuals, is discrimination under the New York Law.”
NYU Langone has not made any advertisement on canceled dates. A hospital spokesman said he had no immediate comment on the message.
Last week, the executive was left many families that are not sure whether their transgender children will be able to receive medical care and the procedures they expected. In interviews, two different families said that 12 -year -old members were to be planted to be planted that would release medications that prevent puberty in the upper arm. But these appointments were suddenly canceled after the executive order.
In the interviews, many parents who are transgender expressed their dissatisfaction not only from the executive matter, but also that hospitals in New York City failed to work as newspapers. They said they were hoping that the sexually transformed children in New York would be isolated from the changes in federal policy.
Throughout the country, more than twenty countries have developed restrictions or a ban on gender care for children, according to the Human Rights campaign. But in New York, some hospitals did not have prosperous practices that provide sexual care for sexually transformed children, but they were also announced. Prominent on the Internet.
However, the executive matter showed the amount of influence of the federal government on hospitals. “It is the United States’ policy that it will not fund, care, promote, assist or support the so -called” transmission “of” child from one sex to another “, the matter began. It threatened to cut the funding of federal research to compel hospitals to stop “chemical and surgical distortion for children”, which is described by the “gender affirmation care” for youth.
Financial effects are enormous, even for a prominent hospital system like Nyu Langone Health. In one year, Nyu Langone Health and her researcher at the College of Medicine at New York University He received $ 815 million in the prizes From the National Institutes of Health.
The executive order also issued instructions to the federal government to study whether Medicare or Medicaid can be used to force hospitals to comply.
In a period of 12 months, NYU Langone has made more than $ 9 billion in patient care. Almost half of this amount – $ 4.4 billion – paid through government insurance programs.
The executive takes a specific goal to describe puberty blockers, hormonal therapy, and various surgical procedures for children with dysphagia, a condition that describes the patient’s distress on the incompatibility between sexual identity and sex at birth.
Wide questions about the medical treatment for young people who seek to move were the subject of discussion in the United States and Europe.
In Europe, there was a clear shift that made some gender -confirmed treatments less available to children. Britain recently banned the use of adulthood in children under the age of 18 due to dysmenorrhea, outside clinical trials.
Puberty blockers are approved by the FDA to treat unusually early puberty, and diseases including prostate cancer and uterine lining. Their use of children with sexual dysfunction is outside the label, although the external prescriptions of the drugs are common.
The exact number of children on puberty blockers for the dyslexia in New York is not clear.
Senator Brad Hileman Seagal said that restricting the sponsorship of the sexual assertion of young people is a threat to their health.
“Simply put this decision, this decision can endanger lives,” the state, which is part of Manhattan, said in a statement. “It is necessary that all New York residents, including those under the age of 19, can obtain a necessary care to influence the gender that are entitled to New York State.”